Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial

BACKGROUND: The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength of evidence from very few clinical trials and some case series reports. Current treatment guidelines recommend pentamidine isethionate or meglumine antimoniate (Glucantime) as the first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Francesconi, Valeska Albuquerque, Francesconi, Fabio, Ramasawmy, Rajendranath, Romero, Gustavo Adolfo Sierra, Alecrim, Maria das Graças Costa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854414/
https://www.ncbi.nlm.nih.gov/pubmed/29481560
http://dx.doi.org/10.1371/journal.pntd.0006225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854414/
https://www.ncbi.nlm.nih.gov/pubmed/29481560
http://dx.doi.org/10.1371/journal.pntd.0006225

Ejemplares similares